颈动脉内膜剥脱或支架后再狭窄的PTFE人工血管旁路术
本研究评估了聚四氟乙烯(PTFE)人工血管颈动脉旁路术(PCB)用于治疗颈动脉内膜剥脱术(CEA)或颈动脉支架置入术(CAS)后再狭窄的效果。研究纳入66例再狭窄≥70%的患者,中位随访5年,结果显示无围手术期死亡或卒中,5年无卒中生存率为93%±2%,表明PCB安全有效。
要点
- PTFE人工血管旁路术治疗颈动脉再狭窄安全,围手术期无死亡或卒中。
- 5年无卒中生存率93%±2%,总体生存率81%±7%。
- 适用于CEA风险高或不建议CEA的再狭窄患者。
核心结论
- 对于CEA或CAS后再狭窄且CEA被认为危险或不建议的患者,PTFE人工血管旁路术是安全、持久的替代方案。
研究设计与样本
- 患者中57例(86%)初次治疗为CEA,9例(14%)为CAS;中位再次血运重建间隔32个月。
- 所有患者接受PTFE人工血管旁路术,中位随访5年。
主要发现
- 围手术期无死亡、卒中或颈部血肿;发生1例暂时性面神经麻痹和2例暂时性喉返神经麻痹。
- 2年和4年时各发生1例与旁路闭塞相关的晚期卒中;未观察到其他移植物狭窄或感染。
- 5年总体生存率为81%±7%,无卒中生存率为93%±2%;无致死性卒中。
关键数值与推荐
- 再狭窄定义采用NASCET标准,≥70%。
- 38例(58%)再狭窄有症状,包括短暂性脑缺血发作(n=20)或卒中(n=18)。
- 使用的PTFE移植物直径6 mm者6例,7 mm者60例;远端吻合方式端端吻合22例,端侧吻合44例。
临床怎么用
- 对于CEA或CAS后再狭窄且CEA风险高或不建议CEA的患者,可考虑PTFE人工血管旁路术。
- 术后应继续他汀和抗血小板治疗,并每6个月进行临床和多普勒超声随访。
局限性
- 样本量较小(66例),来自三个中心,可能存在选择偏倚。
- 非随机对照研究,缺乏与CEA或其他治疗方式的直接比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to evaluate the results of prosthetic carotid bypass (PCB) with polytetrafluoroethylene (PTFE) grafts as an alternative to carotid endarterectomy (CEA) in treatment of restenosis after CEA or carotid artery stenting (CAS). METHODS: From January 2000 to December 2014, 66 patients (57 men and 9 women; mean age, 71 years) presenting with recurrent carotid artery stenosis ≥70% (North American Symptomatic Carotid Endarterectomy Trial [NASCET] criteria) were enrolled in a prospective study in three centers. The study was approved by an Institutional Review Board. Informed consent was obtained from all patients. During the same period, a total of 4321 CEAs were completed in the three centers. In these 66 patients, the primary treatment of the initial carotid artery stenosis was CEA in 57 patients (86%) and CAS in nine patients (14%). The median delay between primary and redo revascularization was 32 months. Carotid restenosis was symptomatic in 38 patients (58%) with transient ischemic attack (n = 20) or stroke (n = 18). In this series, all patients received statins; 28 patients (42%) received dual antiplatelet therapy, and 38 patients (58%) received single antiplatelet therapy. All PCBs were performed under general anesthesia. No shunt was used in this series. Nasal intubation to improve distal control of the internal carotid artery was performed in 33 patients (50%), including those with intrastent restenosis. A PTFE graft of 6 or 7 mm in diameter was used in 6 and 60 patients, respectively. Distal anastomosis was end to end in 22 patients and end to side with a clip distal to the atherosclerotic lesions in 44 patients. Completion angiography was performed in all cases. The patients were discharged under statin and antiplatelet treatment. After discharge, all of the patients underwent clinical and Doppler ultrasound follow-up every 6 months. Median length of follow-up was 5 years. RESULTS: No patient died, sustained a stroke, or presented with a cervical hematoma during the postoperative period. One transient facial nerve palsy and two transient recurrent nerve palsies occurred. Two late strokes in relation to two PCB occlusions occurred at 2 years and 4 years; no other graft stenosis or infection was observed. At 5 years, overall actuarial survival was 81% ± 7%, and the actuarial stroke-free rate was 93% ± 2%. There were no fatal strokes. CONCLUSIONS: PCB with PTFE grafts is a safe and durable alternative to CEA in patients with carotid restenosis after CEA or CAS in situations in which CEA is deemed either hazardous or inadvisable.
引用
- Illuminati G, Belmonte R, Schneider F, et al. Prosthetic bypass for restenosis after endarterectomy or stenting of the carotid artery. J Vasc Surg. 2017. PMID: 28268107. doi:10.1016/j.jvs.2016.11.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。